Cargando…
Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID-19, mainly causes alterations in the respiratory system. In severely ill patients, the disease often evolves into an acute respiratory distress syndrome that can predispose patients to a state of hypercoagulability, w...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245242/ https://www.ncbi.nlm.nih.gov/pubmed/32591185 http://dx.doi.org/10.1016/j.redar.2020.05.007 |
_version_ | 1783537715998883840 |
---|---|
author | Llau, J.V. Ferrandis, R. Sierra, P. Hidalgo, F. Cassinello, C. Gómez-Luque, A. Quintana, M. Amezaga, R. Gero, M. Serrano, A. Marcos, P. |
author_facet | Llau, J.V. Ferrandis, R. Sierra, P. Hidalgo, F. Cassinello, C. Gómez-Luque, A. Quintana, M. Amezaga, R. Gero, M. Serrano, A. Marcos, P. |
author_sort | Llau, J.V. |
collection | PubMed |
description | The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID-19, mainly causes alterations in the respiratory system. In severely ill patients, the disease often evolves into an acute respiratory distress syndrome that can predispose patients to a state of hypercoagulability, with thrombosis at both venous and arterial levels. This predisposition presents a multifactorial physiopathology, related to hypoxia as well as to the severe inflammatory process linked to this pathology, including the additional thrombotic factors present in many of the patients. In view of the need to optimise the management of hypercoagulability, the working groups of the Scientific Societies of Anaesthesiology-Resuscitation and Pain Therapy (SEDAR) and of Intensive, Critical Care Medicine and Coronary Units (SEMICYUC) have developed a consensus to establish guidelines for actions to be taken against alterations in haemostasis observed in severely ill patients with COVID-19. These recommendations include prophylaxis of venous thromboembolic disease in these patients, and in the peripartum, management of patients on long-term antiplatelet or anticoagulant treatment, bleeding complications in the course of the disease, and the interpretation of general alterations in haemostasis. |
format | Online Article Text |
id | pubmed-7245242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72452422020-05-26 Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19 Llau, J.V. Ferrandis, R. Sierra, P. Hidalgo, F. Cassinello, C. Gómez-Luque, A. Quintana, M. Amezaga, R. Gero, M. Serrano, A. Marcos, P. Rev Esp Anestesiol Reanim Article The infection by the coronavirus SARS-CoV-2, which causes the disease called COVID-19, mainly causes alterations in the respiratory system. In severely ill patients, the disease often evolves into an acute respiratory distress syndrome that can predispose patients to a state of hypercoagulability, with thrombosis at both venous and arterial levels. This predisposition presents a multifactorial physiopathology, related to hypoxia as well as to the severe inflammatory process linked to this pathology, including the additional thrombotic factors present in many of the patients. In view of the need to optimise the management of hypercoagulability, the working groups of the Scientific Societies of Anaesthesiology-Resuscitation and Pain Therapy (SEDAR) and of Intensive, Critical Care Medicine and Coronary Units (SEMICYUC) have developed a consensus to establish guidelines for actions to be taken against alterations in haemostasis observed in severely ill patients with COVID-19. These recommendations include prophylaxis of venous thromboembolic disease in these patients, and in the peripartum, management of patients on long-term antiplatelet or anticoagulant treatment, bleeding complications in the course of the disease, and the interpretation of general alterations in haemostasis. Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. 2020 2020-05-23 /pmc/articles/PMC7245242/ /pubmed/32591185 http://dx.doi.org/10.1016/j.redar.2020.05.007 Text en © 2020 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Llau, J.V. Ferrandis, R. Sierra, P. Hidalgo, F. Cassinello, C. Gómez-Luque, A. Quintana, M. Amezaga, R. Gero, M. Serrano, A. Marcos, P. Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19 |
title | Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19 |
title_full | Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19 |
title_fullStr | Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19 |
title_full_unstemmed | Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19 |
title_short | Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19 |
title_sort | recomendaciones de consenso sedar-semicyuc sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245242/ https://www.ncbi.nlm.nih.gov/pubmed/32591185 http://dx.doi.org/10.1016/j.redar.2020.05.007 |
work_keys_str_mv | AT llaujv recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT ferrandisr recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT sierrap recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT hidalgof recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT cassinelloc recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT gomezluquea recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT quintanam recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT amezagar recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT gerom recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT serranoa recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 AT marcosp recomendacionesdeconsensosedarsemicyucsobreelmanejodelasalteracionesdelahemostasiaenlospacientesgravesconinfeccionporcovid19 |